Educational and Professional Background
B.A. Chemistry (Cum Laude) - Brooklyn College, City University of New York, 1972
M.D. Downstate Medical Center, State University of New York, 1976
Internship (PGYI): Maimonides Medical Center 1976-1977 Brooklyn, NY (Internal Medicine)
Residency (PGYII): same, 1977-1978 (Internal Medicine)
Residency (PGYIII): Columbia Presbyterian Hospital, 1978-1979 New York, NY (Internal Medicine)
Fellowship: UCLA Medical Center, Department of Medicine, 1979-1982, Division of Infectious Diseases, Los Angeles, CA, 90095
National Board of Medical Examiner, 1976
American Board of Internal Medicine, 1980
Subspecialty Board of Infectious Diseases, 1982
Associate Division Chief, Infectious Disease Division, Greater Los Angeles Healthcare System, Department of Veterans Affairs, since 1991 to present
Clinical Professor, Department of Medicine, David Geffen School of Medicine of UCLA, and Department of Oral Biology and Oral Medicine, UCLA School of Dentistry
Previous positions :
Division of Infectious Diseases, Center for Health Sciences, UCLA, 1982-1993
Comprehensive Medical Care, Beverly Hills, CA, 1982-1988
The Henry R. Vietz Fellowship of the Myasthenia Gravis Foundation for Research into the Application of Electromagnetics to Augment Muscular and Cardiovascular Functions, 1974
Professional memberships and activities:
Committee Service:
Chairman, Medical Service Mortality Review Conference, Wadsworth Veterans Hospital, 1987-1988
Admissions Committee, UCLA School of Dentistry, 1991-1999
Human Subjects Committee, Mount St. Mary's College, 1991-1993
Resident evaluation Committee, Greater Los Angeles Healthcare System, Department of Veterans Affairs, 1998 – to present
Scholarly Societies:
American College of Physicians
American Association for the Advancement of Science
American Society for Microbiology
American Federation for Clinical Research
International Society for Human and Animal Mycology
Infectious Diseases Society of America
Reviewing activities:
Manuscript review for Infection and Immunity, Clinical Infectious Diseases, Journal of Infectious Diseases, Blood, AIDS Journal.
Ad hoc reviewer for Veterans Administration Career Development Grants and Merit Review.
Recent Publications
Lehrer RI, Szklarek D, Selsted ME and Fleischmann J. Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun 33:775-778, 1981.
Winston DJ, Kurtz TO, Fleischmann J, Morgan D, Batzdorf U and Sterb WE. Successful treatment of spina arachnoiditis due to coccidioidomycosis. J. Neurosurgery 59:328-331, 1983.
Lehrer RI, Selsted ME, Szklarek D and Fleischmann J.Antibacterial activity of microbicidal cationic proteins I and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun 42:10-16, 1983.
Fleischmann J, Selsted ME and Lehrer RI . Opsonic activity of MCP I and MCP2, cationic peptides from rabbit lung macrophages. Diag Microbiol Infect Dis 3:233-242, 1985.
Fleischmann J, Church J and Lehrer RI . Case report: Primary candida meningitis and chronic granulomatous disease. The American Journal of the Medical Sciences 291:334-341, 1986.
Fleischmann J, Golde DW, Weisbart RE and Gasson JC. Granulocyte-Macrophage Colony Stimulating Factor Enhances Phagocytosis of bacteria by Human Neutrophils. Blood 68:708711, 1986.
Baldwin GC, Gasson JC, Quan SG, Fleischmann J, Weisbart RR, Oette D, Mitsuyasu RT and Golde DW. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc. Natl. Acad. Sci USA 85:2763-2766. 1988.
Fleischmann J and Howard DII. The DNA content of non-germinative variants of Candida albicans. Nucleic Acids Research 16:765, 1988.
Fleischmann J, Wu-Hsie H and Howard DH. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human gamma-interferon. J. Infect. Dis. 161:143-145, 1990.
Baldwin GC, Fleischmann J, Chung Y, Koyanagi Y, Chen ISY, and Golde DW. Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc. Natl. Acad. Sci. USA , 87:3933-3937, 1990.
Clancy NIN, Fleishmann J, Howard DH, Kwon-Chung KJ, and Shimizu RY Isolation of Cryptococcus neoformans v. gatti from a patient with AIDS in Southern California. J. Infect. Dis. 161:809, 1990.
McCarthy JD, Fleischmann J, and George WL. Fever, Dyspnea, and Slurred Speech Following Lower Extremity Trauma. Rev. Infect. Dis. 13:172-176, 1991.
Lovett MA, Goldstein EJC and Fleischmann J. Fever in a Couple Vacationing in the Mountains of Southern California. Clin Inf. Dis . 14:1254-1258, 1992.
Campbell DA, Kurath U and Fleischmann J. Identification of a gp63 surface glycoprotein in Leishmania tarentolae. FEMS Microbiol Lett . 96:89-92, 1992.
Eversole LR, Fleischmann J, Baldwin GC and Sapp JP. The effects of human immunodeficiency virus infection on macrophage phagocytosis of Candida. Oral Microbiol. Immunol. 9: 55-59,1994.
Fleischmann J and Campbell DA. Expression of the Leshmania tarentolae ubiquitin-encoding and mini-exon genes. Gene. 144:45-51, 1994.
Sturm N, Fleischmann J, and Campbell DA. Efficient trans-splicing of mutated spliced leader exons in Leishmania tarentolae. J. Biol. Chem. 273:18689-18692, 1998.
Fleischmann J and Liu H. Polyadenylation of ribosomal RNA by Candida albicans. Gene 265:71-76, 2001.
Sen BH, Chugal NM, Liu H, Fleischmann J. A new method for studying the adhesion of Candida albicans to dentin in the presence or absence of smear layer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . Aug;96:201-6, 2003.
Additional Information
The Alan Teitler Memorial Award for Excellence in Medicine and Outstanding Intern 1976-1977
|
